Main Article Content
: Mycobacterium tuberculosis (MTB), rifampicin resistance, multi-drug resistance (MDR), Gene X pert MTB/RIF
Tuberculosis has been potentially diagnosed by an innovative Gene Xpert Mycobacterium tuberculosis refampcin tool substantially impacted the quick detection of RIF resistance in clinical samples, Multi drug-resistant tuberculosis signify the remarkable resistance to the conventional (isoniazid, rifampicin against tuberculosis.
The gene x pert MTB/RIF has been clinically and microscopically utilized for the detection of the multivariate pulmonary specimens of early pulmonary tuberculosis cases. Robust screening study had been implemented at Erbil community in the chest and respiratory diseases centre in the period June 2017- June 2018.
Two hundred fifty Sputum samples were obtained from TB suspects. All samples were tested on Gene X pert for MTB/RIF detection after acid fast bacilli microscopy.75(30%) sputum samples were AFB smear positive and 175 (70%) were negative. In MTB/RIF assay 85 (34%) were MTB positive and 165 (66%) were negative. The MTB/RIF assay also detected 7 RIF-resistant specimen and 78 RIF-susceptible specimens, and the results were confirmed by drug susceptibility testing. Sensitivity and specificity of Gene x pert were 100% and 94.29% respectively, compared with the conventional method.
Hence from the overall conclusion, we can acknowledge that the MTB/RIF assay has simplified and solve the dramatic challenge of multiple TB cases and cut short with positive impact the dilemma of empirical TB treatment drugs
Arzu N. Zeka, Sezai Tasbakan and Cengiz Cavusoglu.2011. Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens. 10.1128/JCM.05434-11
Kheira Guenaoui, Noria Harir, Aissa Ouardi, Soumia Zeggai, Feriel Sellam, Farid Bekri, and Sakina Cherif Touil.2016. Use of Gene Xpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin-resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases. Ann Transl Med; 4(9): 168.
WHO. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. World Health Organization, Geneva, Switzerland. Google Scholar
Panayotis Ioannidis*, Dimitrios Papaventsis, Simona Karabela, Stavroula Nikolaou, Marina Panagi, Ekaterini Raftopoulou, Eythymia Konstantinidou, Ioanna Marinou and Sofia Kanavaki .2011. Cepheid GeneXpert MTB/RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results. 10.1128/JCM.00718-11
Giulia Lombardi,1,* Valentina Di Gregori,2 Nicolò Girometti,3 Marina Tadolini,3 Francesco Bisognin,1 and Paola Dal Monte1 .2017. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF. 12(4): e0176186.
Lewinsohn, D. M., Leonard, M. K., Lobue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., et al. 2017. Official American thoracic society/infectious diseases society of America/ centres for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin. Infect. Dis. 64, 111–115. doi: 10.1093/cid/ciw778
WHO (2017).Global Tuberculosis Report 2016.Geneva: WHO.
Detjen, A. K., Dinardo, A. R., Leyden, J., Steingart, K. R., Menzies, D., Schiller, I., etal.(2015).XpertMTB/RIFassayforthediagnosisofpulmonarytuberculosis in children: a systematic review and meta-analysis. Lancet Respir. Med. 3, 451–461.doi:10.1016/S2213-2600(15)00095-88
Luetkemeyer, A. F., Firnhaber, C., Kendall, M. A., Wu, X., Mazurek, G. H., Benator, D. A., et al. 2016. Evaluation of Xpert MTB/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings. Clin. Infect. Dis. 62, 1081–1088. doi: 10.1093/cid/ciw035
September 2018CLSI Publishes New Microbiology Guideline, M48—Laboratory Detection and Identification of Mycobacteria
Zhang, A. M., Li, F., Liu, X. H., Xia, L., and Lu, S. H. (2016). Application of Gene Xpert Mycobacterium tuberculosis DNA and resistance to rifampicin assay in the rapid detection of tuberculosis in children. Zhonghua Er Ke Za Zhi 54, 370–374. doi: 10.3760/cma.j.issn.0578-1310.2016.05.012
Nguyen,ho.j, P. T., Nguyen, T. A., Tran, K. H., Van Nguyen, S., Nguyen, N. V., et al. (2016). Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis. Lancet Infect. Dis. 16, 1045–1051. doi: 10.1016/S1473-3099(16)30067-6
Dereje Assefa Geleta1*, Yoseph Cherinet Megerssa2, Adugna Negussie Gudeta3, Gizachew Taddesse Akalu4, Melaku Tesfaye Debele5 and Kassu Desta Tulu6 Geleta et al.2015. . Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. . BMC Microbiology .15:220 DOI 10.1186/s12866-015-0566-6
Wu, B., Yu, Y., Xie, W., Liu, Y., Zhang, Y., Hu, D., et al. 2017. Epidemiology of tuberculosis in Chongqing, China: a secular trend from 1992 to 2015. Sci. Rep. 7:7832. doi: 10.1038/s41598-017-07959-2
Meyer, A. J., Atuheire, C., Worodria, W., Kizito, S., Katamba, A., Sanyu, I., et al. 2017. Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda. PLoS One 12:e0180572. doi: 10.1371/journal.pone.0180572
Chakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., et al. 2017. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and
Xiaofu Pan, Shoufeng Yang, Margaret A. Deighton, Yue Qu, Liang Hong and Feifei Su..2018 A Comprehensive Evaluation of Xpert MTB/RIF Assay With Bronchoalveolar Lavage Fluid as a Single Test or Combined With Conventional Assays for Diagnosis of Pulmonary Tuberculosis in China: A Two-Center Prospective Study. Front. Microbiol., 13 March 2018 | https://doi.org/10.3389/fmicb.2018.00444
Singh, M., Sethi, G. R., Mantan, M., Khanna, A., and Hanif, M. 2016. Xpert((R)) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children. Int. J. Tuberc. Lung Dis. 20, 839–843. doi: 10.5588/ijtld.15.0824
Walters, E., Demers, A. M., Van Der Zalm, M. M., Whitelaw, A., Palmer, M., Bosch, C., et al. (2017). Stool culture for diagnosis of pulmonary tuberculosis in children. J. Clin. Microbiol. 33, 3355–3365. doi: 10.1128/JCM.00801-17
WHO. [24.09.2018]. Available from: http://www.emro.who.int/irq/programmes/tuberculosis.html
Williamson DA, Basu I, Bower J, Freeman JT, Henderson G.2012 An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis.; 74(2):207–9.
Carriquiry G, Otero L, Gonza’lez-Lagos E, Zamudio C, Sanchez E, et al. 2012 Diagnostic accuracy study of Xpert MTB/RIF in HIV positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLoS One. ; 7(9):e44626.
Balcha TT, Sturegard E, Winqvist N, Skogmar S, Reepalu A, et al. 2014 Intensified Tuberculosis Case-Finding In HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture. PLoS One. ; 9(1):e85478.
Causse M, Ruiz P, Gutie’rrez-Aroca JB, Casal M.2011 Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol. ; 49(8):3065–7.hyponatremia during therapy with fluoxetine. Arch Intern Med, 156, 681-2.